UNIVERSITY OF NOTRE DAME DU LAC
The long-term goal of this proposal is to identify functions and determine mechanisms of the fibrinolytic system, and its inhibitors, in physiological and pathological processes utilizing cell based and in vivo models. The availability of mice with deficiencies of genes of the fibrinolytic system has resulted in direct analyses of the role of these proteins in a number of biological events. Studies have indicated that a PAI-1 deficiency diminishes angiogenesis in tumor models. Further, our laboratory has shown that endothelial cell (EC) signaling and function are regulated by PAI-1/LRP interactions. The current application will further elucidate effects of PAI-1 on cell signaling pathways and determine the importance of PAI-1/LRP interactions in both cellular and physiological events. As a result of these observations, the following studies are proposed:
(1.) Determine the effects of a PAI-1 deficiency on murine EC JAK/STAT signaling and cell cycle progression. These studies will assess STAT and JAK expression profiles and activation status in proliferating wild-type (WT) and PAI-1-/- EC as well as the extent of nuclear translocation of STAT. The addition of rPAI-1 and mutants will determine which functional domains of PAI-1 regulate the activation status of this pathway. Additional studies will determine effects on cell migration. Downstream effects on cell cycle progression will also be investigated. The hypothesis is that a PAI-1 deficiency will affect JAK/STAT signaling and downstream cell cycle progression, and that these effects are mediated by PAI-1/LRP interactions.
(2.) Generate and characterize mice expressing PAI-1 protein with a deficit in interaction capabilities with LRP. Studies have shown that PAI-1-/- mice develop cardiac fibrosis. Since this phenotype may be attributable to chronic Akt activation, cardiac function as well as the extent of cardiac fibrosis will be determined in these mice and compared to PAI-1-/- mice. The hypothesis is that mice expressing PAI-1 with a deficit in LRP interaction will mimic, at least to some extent, cardiac fibrosis phenotype seen in PAI-1-/- mice. (3.) Determine effects of PAI-1 with disrupted LRP interaction capacity on EC proliferation, migration, cell signaling, and angiogenesis. These studies will examine whether regulated endogenous expression of PAI-1 with a deficit in LRP binding in EC mimics exogenous effects of rPAI-1, and whether these effects alter capillary formation and angiogenesis in vivo. The hypothesis is that EC from mice expressing this mutant PAI-1 will mimic PAI-1-/- EC with respect to cell proliferation, cell signaling, and apoptosis and this will have profound effects on EC biology.
Choose a quarter and click "Go."
| AWARD OVERVIEW |
| Award Number |
2R01HL063682-09A1 |
Funding Agency |
Department of Health and Human Services |
| Total Award Amount |
$750,000 |
Project Location - City |
Notre Dame |
| Award Date |
06/15/2009 |
Project Location - State |
IN |
| Project Status |
More than 50% Completed |
Project Location - Zip |
46556-5602
|
| Jobs Reported |
0.00 |
Congressional District |
02 |
| Project Location - Country |
US |
|
|
Recipient Information
(Grants)
| Recipient Information (Grants) |
|
Recipient Name
|
UNIVERSITY OF NOTRE DAME DU LAC |
| Recipient DUNS Number |
824910376
|
| Recipient Address |
511 MAIN BUILDING |
| Recipient City |
NOTRE DAME |
| Recipient State |
Indiana |
| Recipient Zip |
46556-5602 |
| Recipient Congressional District |
02 |
| Recipient Country |
USA |
Required to Report Top 5 Highly Compensated Officials |
No |
Projects and Jobs Information
| Projects and Jobs Information |
| Project Title |
Pathological Consequences of the Plasminogen System |
| Project Status |
More than 50% Completed |
| Final Project Report Submitted |
No |
| Project Activities Description |
Medical Research, General/Other |
| Quarterly Activities/Project Description |
We are currently using a method of chemically enhancing the development of cardiac fibrosis. This model is a short term model (longest timepont is 4 wk post induction) and involves implanting an osmotic pump containing angiotensin and a pellet that releases aldosterone. This increases the blood pressurre in the mice thereby facilitaing the fibrosis process. Collagen deposition is still enhanced in mice with a double deficiency of PAI-1 and urokinase. Interesting mice expressing a mutant PAI-1 which has lost it's ability to bind vitronectin resolves the collagen phenotype seen in PAI-1 deficient (PAI-1-/-) mice indicating that loss of PAI-1's ability to bind vitronectin does not contribute to enhanced collagen deposition. Additionally, the bleeding phenotype observed in PAI-1-/- mice is resolved in mice expressing the mutant PAI-1. This could indicate that if there is no early bleeding events there is no collagen build-up. Finally, leukocyte accumulation is also diminished in the mice expressing the mutant PAI-1 relative to PAI-1-/- mice. We are currently increasing our n values for these studies in order to determine if the differences are statistically significant. |
| Jobs Created |
0.00 |
| Description of Jobs Created |
None in this quarter |
Purchaser Information
(Grants)
| Purchaser Information |
| Contracting Office ID |
Not Reported |
| Contracting Office Name |
Not Available |
| Contracting Office Region |
Not Available |
| TAS Major Program |
75-0871 |
| Award Information |
| Award Date |
06/15/2009 |
| Award Number |
2R01HL063682-09A1 |
| Order Number |
|
| Award Type |
Grants |
| Funding Agency ID |
75 |
| Funding Agency Name |
Department of Health and Human Services |
| Funding Office Name |
Not Available |
| Awarding Agency ID |
75 |
| Awarding Agency Name |
Department of Health and Human Services |
| Amount of Award |
$750,000 |
| Funds Invoiced/Received |
$742,294 |
| Expenditure Amount |
$745,294 |
| Infrastructure Expenditure Amount |
$0 |
| Infrastructure Purpose and Rationale |
Not Reported |
| Infrastructure Point of Contact Name |
N/A |
| Infrastructure Point of Contact Email |
Not Reported |
| Infrastructure Point of Contact Phone |
Not Reported |
| Infrastructure Point of Contact Address |
N/A |
| Infrastructure Point of Contact City |
N/A |
| Infrastructure Point of Contact State |
Not Reported |
| Infrastructure Point of Contact Zip |
Not Reported |
Product or Service Information
(Grants)
| Product or Service Information |
| Primary Activity Code |
H01 |
| Activity Description |
Medical Research, General/Other |
| Sub-Awards Information |
| Sub-awards to Organizations |
0 |
| Sub-award Amounts to Organizations |
$0 |
| Sub-Awards to Individuals |
0 |
| Sub-Award Amounts to Individuals |
$0 |
| Number of Sub-awards less than $25,000/award |
0 |
| Amount of Sub-awards less than $25,000/award |
$0 |
| Number of payments to vendors greater than $25,000 |
0 |
| Total Amount of payments to vendors greater than $25,000/award |
$0 |
| Number of payments to vendors less than $25,000/award |
449 |
| Total Amount of payments to vendors less than $25,000/award |
$187,917 |
| Location Information |
| Latitude, Longitude |
41º 42' 8",
-86º 14' 48" |
| Congressional District |
02 |
| Address 1 |
511 Main Building |
| Address 2 |
|
| City |
Notre Dame |
| County |
St. Joseph |
| State |
IN |
| Zip |
46556-5602 |
|
|